COVID : BDR Pharma enters into agreement with Eli Lilly for manufacturing of Baricitinib
BDR Pharma, one of India’s leading generic pharmaceutical, on Wednesday announced that it has entered into a royalty-free, limited and ...
BDR Pharma, one of India’s leading generic pharmaceutical, on Wednesday announced that it has entered into a royalty-free, limited and ...
MSN Labs (MSN) on Thursday announced that they have entered into a royalty free, non-exclusive, voluntary license agreement with the ...
Pharma major, Dr Reddy's Labs on Wednesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with ...
© Janam Multimedia Limited